Aigh Capital Management LLC Mirum Pharmaceuticals, Inc. Transaction History

Aigh Capital Management LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 12, 2022	SELL	$15.5 - $23.93 $5.24 Million - $8.09 Million	-337,917 Closed	0 $0
Q4 2021 Feb 10, 2022	BUY	$13.05 - $19.35 $4.41 Million - $6.54 Million	337,917 New	337,917 $5.39 Million
Q1 2021 May 13, 2021	SELL	$16.29 - $21.92 $4.47 Million - $6.02 Million	-274,583 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$15.75 - $25.45 $4.32 Million - $6.99 Million	274,583 New	274,583 $4.79 Million

172

54.2M

96.1K

54.8K

Ticker MIRM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,751,700
Market Cap $1.43B
Description
Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the trea...

Get notified when there are updates to the investment portfolio of Aigh Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Aigh Capital Management LLC with notifications on news.